All relevant data are within the paper and its Supporting Information files. Raw sequencing data is deposited at GEO (Accession Number: GSE65944) and available in the database (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65944>).

Introduction {#sec001}
============

During space flight, astronauts are exposed to powerful environmental assaults such as microgravity, cosmic radiation and magnetic fields that have the potential to impinge upon cellular ontogeny through epigenetic modifications \[[@pone.0147514.ref001]\]. Throughout the evolutionary history, gravity has been a constant factor in defining the architecture and morphology of living beings \[[@pone.0147514.ref002]\]. Hence a broader understanding of gravity's influence on biological functions is important for an accurate evaluation of risks associated with the health of astronauts in spaceflights and should be of enormous interest to the scientific community. The effects of microgravity in altering gene expression have been documented in mammalian cells \[[@pone.0147514.ref003], [@pone.0147514.ref004]\] and other model organisms, such as yeast and bacteria \[[@pone.0147514.ref005]--[@pone.0147514.ref007]\]. Microgravity associated pathological alterations include reduction in bone mass and calcium concentrations \[[@pone.0147514.ref008]\], alterations in hormonal levels \[[@pone.0147514.ref009]\], impairment of immunocompetence \[[@pone.0147514.ref010]\] and apoptosis signaling \[[@pone.0147514.ref011]\]. Studies of human lymphoblast and lymphoblast cell cultures following periods of simulated microgravity have demonstrated alterations in metabolic processes and DNA repair pathways which could in turn signify an increased susceptibility to malignancy \[[@pone.0147514.ref012], [@pone.0147514.ref013]\]. Collectively, these studies indicate exposure to microgravity during space flight alters gene expression patterns and subsequently cellular physiology.

DNA methylation is regarded as a major epigenetic mechanism and play key roles in regulating cellular processes in living organisms \[[@pone.0147514.ref014], [@pone.0147514.ref015]\]. Biochemically, DNA methylation refers to the addition of a methyl group (CH~3~) to the 5' carbon on the pyrimidine ring of cytosine nucleotides (commonly abbreviated as 5mC). Aberrations in genome-wide 5mC patterns are widely prevalent in cancer and other diseases \[[@pone.0147514.ref014], [@pone.0147514.ref016]--[@pone.0147514.ref018]\]. Traditionally DNA methylation marks have been associated with "transcriptionally silent" genes, however the revelations of global methylation studies facilitated by recent advances in Next Generation Sequencing (NGS) tools have established that the role of 5mC in regulating gene expression is complex, varies according to the genomic context and warrants extensive explorations \[[@pone.0147514.ref019]--[@pone.0147514.ref025]\]. Discovered in 2009, DNA hydroxymethylation (5hmC) is a relatively new epigenetic modification occurring on Cytosine \[[@pone.0147514.ref026], [@pone.0147514.ref027]\] generated by Ten-Eleven Translocation (TET) protein- mediated oxidative catalysis of 5mC \[[@pone.0147514.ref026]\]. Though, potential roles of 5hmC at promoter and gene bodies are not clearly understood, it is shown to play some role in maintaining and/or promoting gene expression \[[@pone.0147514.ref014], [@pone.0147514.ref016]--[@pone.0147514.ref018], [@pone.0147514.ref028]\]. Microgravity induced alteration in DNA methylation patterns have been reported previously \[[@pone.0147514.ref029]--[@pone.0147514.ref031]\] but the effect of microgravity on 5hmC is virtually unknown. During the time period this study was being conducted there were no reports of a NGS based study documenting the effects of microgravity on the epigenomic landscape.

The goal of our study was to profile genome-wide effects of "simulated" microgravity on 5mC, 5hmC and gene expression patterns employing Next Generation Sequencing (**[Fig 1](#pone.0147514.g001){ref-type="fig"}**). The TK6 lymphoblastoid cell line, derived from T cell blast crisis of a patient with chronic myelogeneous leukemia \[[@pone.0147514.ref032]\], served as our model organism. TK6 cells are well characterized and have been extensively used as a substitute for peripheral blood lymphocytes for immunological and epidemiological studies \[[@pone.0147514.ref013]\]. The limited availability of biological specimen subjected to conditions of microgravity in spaceflights makes ground based "simulated" microgravity studies critical in determining thresholds and thorough testing of the model organism before conducting the experiments during space missions \[[@pone.0147514.ref033]\]. A High Aspect Ratio Vessel (HARV) based rotary cell culture system (initially developed by NASA) was used in our study to "simulate" microgravity in the TK6 cells as has been described previously \[[@pone.0147514.ref034]\] and compared to a control static cell-culture system under the influence of earth's gravity. While assessing the merits of ground based "simulation" studies, it has to be appreciated that the effects of gravity cannot be completely negated but reduced to near zero to achieve a state of "functional near weightlessness" \[[@pone.0147514.ref033]\].

![Schematic illustration of the bioinformatics pipeline for MeDIP-seq, hMeDIP-seq and RNA-seq analysis used in our study to understand the DNA methylation and hydroxymethylation and gene expression patterns induced by simulated microgravity.\
All steps were done in parallel in TK6 subjected to "simulated" microgravity and static controls under the influence of Earth's gravitational force.](pone.0147514.g001){#pone.0147514.g001}

Materials and Methods {#sec002}
=====================

Cell culture {#sec003}
------------

TK6 human lymphoblastoid cells (ATCC, Manassas, VA) were maintained in the log phase of cell growth by culturing in RPMI-1640 (Life Technologies, Grand Island, NY) medium supplemented with 10% Fetal Bovine Serum (Atlanta Biologicals, Flowery Branch, GA) and 1% Penicillin/Streptomycin (Life Technologies, Grand Island, NY) at 37°C in 5% CO~2~ and 95% air. For ground-based simulation of microgravity, HARV Rotary Cell Culture System (Synthecon, Houston, TX) was used. Actively growing TK6 cells were seeded in the bioreactor at 2 ~X~ 10^5^ cells/ml and rotated at 12 rpm/min. In parallel, cells (at the same cellular density i.e. 2 ~X~ 10^5^ cells/ml) were maintained in bioreactors in normal gravity (static) condition as controls. The bioreactors were maintained in an incubator at 37°C, with 5% CO~2~ and 95% air for 48 hours.

DNA isolation, sonication and adapter ligation {#sec004}
----------------------------------------------

Genomic DNA was isolated from the TK6 cells cultured under microgravity and control static conditions using the DNeasy Blood &Tissue kit (Qiagen Inc., Valencia, CA) following manufacturer's instructions. 2.5 μg of genomic DNA from each sample was sheared using Covaris S2 Device (Covaris Inc., Woburn, MA). Sheared DNA was purified by binding to AmPure beads (Beckman Coulter Inc.) and End-repair performed by incubating sonicated DNA and End repair solution (New England Biolabs Inc., Ipswich, MA) as per manufacturer's specifications. A-tailing was obtained by incubating the end repaired DNA with dA-tailing mix (New England Biolabs Inc., Ipswich, MA) at 37°C for 30 minutes. At this stage, to facilitate multiplexing each sample was equally divided in two parts (one half for MeDIP and the other half for hMeDIP respectively). Blunt end ligation was performed by incubating the A-tailed DNA samples (1 μg) with unmethylated versions of adapters (IDT Inc., Coralville, IA) based on sequences of the methylated Truseq adapters (Illumina Inc., San Diego, CA) for multiplexing. Thus 8 libraries were prepared as described above. Samples were assayed by qPCR in duplicate and standard curve constructed to establish the molarities of the libraries.

MeDIP-seq /hMeDIP-seq {#sec005}
---------------------

MeDIP and hMeDIP were performed using the methylated/hydroxymethylated DNA enrichment kits (Diagenode Inc., Denville, NJ) following the manufacturer's protocol. Briefly, to 1.2 μg of adapter ligated sonicated genomic DNA, three DNA controls (known sequences bearing unmethylated, methylated or hydroxymethylated Cytosines respectively to assess the efficiency of immunoprecipitation reactions) were spiked-in. The concentration of genomic DNA was adjusted to incorporate the addition of the adapter sequences, preserving the appropriate molar ratio between the genomic DNA and anti-5mC/anti-5hmC antibody during MeDIP/hMeDIP as described by Butcher *et al*. \[[@pone.0147514.ref035]\]: $$\left\lbrack \mathbf{c}\mathbf{o}\mathbf{n}\mathbf{c}.gDNA \right\rbrack = \frac{\left\lbrack {\mathbf{c}\mathbf{o}\mathbf{n}\mathbf{c}.adapter\ ligated\ gDNA} \right\rbrack\ *\ \mathbf{b}\mathbf{p}sonicated\ gDNA}{\mathbf{b}\mathbf{p}sonicated\ gDNA + \mathbf{b}\mathbf{p}adapter\ DNA}$$

Where, $Conc\left( adjusted \right) = \frac{Conc\left( ligated \right)}{\left\{ \frac{bp\left( {sample} \right) + bp\left( adapter \right.}{bp\left( sample \right)} \right\}}$

**conc.***gDNA ➔* adjusted genomic DNA concentration in the adapter ligated libraries,

**conc.***adapter ligated gDNA ➔* concentration of the adapter ligated gDNA libraries,

**bp***sonicated gDNA ➔* average size of the pre-ligation sonicated gDNA and

**bp***adapter DNA ➔* average size of the adapters

After incubation at 95°C to denature the double stranded DNA, immunoprecipitation was performed by incubation with monoclonal antibody directed against 5mC/5hmC (Diagenode Inc., Denville, NJ) and secondary antibody with magnetic bead conjugates (Diagenode Inc., Denville, NJ) overnight at 4°C while being spun continuously at 40 rpm. The captured 5mC/5hmC bearing DNA fragments were separated from the others by magnetic pulldown. After repeated cleanups, the captured DNA was isolated from the magnetic beads bearing antibody using the IPure kit (Diagenode Inc., Denville, NJ). The enrichment of 5mC/5hmC bearing DNA was assessed by performing qPCR on the pre and post immunoprecipitated samples. As a control, an identical immunoprecipitation reaction with mouse IgG instead of monoclonal 5mC/5hmC antibody was performed. The methylated/hydroxymethylated DNA immunoprecipitated libraries were amplified by PCR and submitted to the Purdue Genomics Core Facility for high-throughput sequencing by Hi Seq 2000 (Illumina Inc., San Diego, CA).

MeDIP-seq and hMeDIP-seq data processing {#sec006}
----------------------------------------

FastQC v 0.10.1 \[[@pone.0147514.ref036]\] was used to assess the quality of the reads and to generate graphical representations of numerous quality metrics (per base sequence quality, GC content and sequence duplication/size distribution levels). The reads were aligned to human reference genome hg19 using BWA v 0.6.2 \[[@pone.0147514.ref037]\], with default parameters and a maximum insert size of 400 bp. The resulting SAM files were converted to BAM format and sorted using Samtools v0.1.18 \[[@pone.0147514.ref038]\] as illustrated in (**[Fig 1](#pone.0147514.g001){ref-type="fig"}**). PERL script from the MeDUSA package \[[@pone.0147514.ref039]\] was used to convert the BAM files to BED format. Since the MEDIPS v1.0 \[[@pone.0147514.ref040]\] package requires only selective fields as input, the BED format was then reduced to four fields using the UNIX cut option. The MeDUSA pipeline utilizes the Bioconductor package MEDIPS v1.0 and custom R scripts to calculate quality metrics for the MeDIP-seq data were designed. The data was normalized for the size of the sequence libraries by calculating reads per million (RPM) in tiled windows across the genome. Wig files obtained for the normalized read depth following alignment and filtering were presented as RPM. Quality check on the MeDIP-seq data was also performed by calculating CpG enrichment values, saturation plots and coverage plots. Genome-wide correlations between the replicates were performed as a quality check for consistency among the replicates using QCSeqs from the Useq package (v8.40) \[[@pone.0147514.ref041]\] using a window size of 500 bp, increasing in 250 bp increments and a minimum number of 5 reads in a window.

Identification of DMRs and DHMRs {#sec007}
--------------------------------

Peak calling software SPP v1.10 \[[@pone.0147514.ref042]\], was used to call peaks and rank them based on significance of enrichment (p-values and false discovery rates). IDR (Irreproducible Discovery Rate) framework was used to measure experiment quality in terms of reproducibility \[[@pone.0147514.ref043]\] and to select the reproducible, consistent peaks (overlapped significant peaks from both replicates) determined based on IDR values. The threshold of 0.05 IDR was used for truncating the peak list as suggested by the developers. The differentially methylated/hydroxymethylated regions identified by IDR analyses were then annotated with their chromosomal locations and feature types for further biological interpretation using custom Perl scripts of MeDUSA package, BEDTools \[[@pone.0147514.ref044]\] and feature annotation files (GFF files from UCSC) as illustrated in **[Fig 1](#pone.0147514.g001){ref-type="fig"}**. Further annotation (plots for enrichment of 5mC/5hmC) was done using CEAS (v1.02) \[[@pone.0147514.ref045]\] and proximity of the peaks to the TSS was determined using PeakAnalyzer \[[@pone.0147514.ref046]\]. The FDR value of 0.05 was used as cut-off for all peak association studies. The complete MeDIP-seq and hmeDIP-seq data was submitted to NCBI GEO (GSE65944) and available in the database <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65944>).

RNA-seq {#sec008}
-------

Total RNA was extracted from cells subjected to simulated microgravity and static control using RNA-STAT-60 (Tel-Test,Inc., Friendswood, TX) using the manufacturer's instructions. Briefly, 1ml of RNA-STAT solution was added per 10^6^ cells and homogenized for 5 minutes over ice. 1ml of chloroform was added, contents shaken vigorously and centrifuged at 12,000g at 4°C for 15 minutes. The aqueous solution was transferred to corex tube (Corning Inc., Lowell, MA) and 0.8 ml isopropanol added. After incubation of 10 minutes, the contents were centrifuged at 12,000g for another 10 minutes to precipitate the RNA. The RNA pellet was washed with 75% ethanol and centrifuged at 7,500g for 5 minutes at 4°C. The ethanol was aspirated and the RNA pellet dried. The RNA pellet was finally resuspended in DEPC water and submitted to the Purdue Genomic Center for conversion into cDNA, sonication, adapter ligation and sequencing as described previously. The reads (fastq files) were aligned to human reference genome hg19 using Tophat v2.1.0 \[[@pone.0147514.ref047]\], with default parameters and known transcriptome as illustrated in **[Fig 1](#pone.0147514.g001){ref-type="fig"}**. Alignment results were filtered by Bamutils v0.5.0 \[[@pone.0147514.ref048]\] to remove reads with multiple mappings. Statistics data of the resulting alignment files were created using Samtools v0.1.18 \[[@pone.0147514.ref049]\] and Bamutils v0.5.0. The counts of aligned reads mapping to known genes were calculated using bamutils v0.5.0. EdgeR v2.11 \[[@pone.0147514.ref050]\] was used to compute the differentially expressed genes. Pathway analysis on the set of differentially expressed genes was done using the GeneCodis3 software designed at the Complutense University of Madrid \[[@pone.0147514.ref051]\].The complete RNA-seq data was submitted to NCBI GEO (GSE65944) and available in the database (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65944>).

Results {#sec009}
=======

Effect of simulated microgravity on cell growth and viability {#sec010}
-------------------------------------------------------------

The effect of simulated microgravity on cell growth and viability 48 hours after the cells were seeded in bioreactors in either the rotating or static condition was determined using Trypan Blue staining method by Automated Cell Counter (Nexcelom Bioscience LLC., Lawrence, MA) in **[S1 Fig](#pone.0147514.s001){ref-type="supplementary-material"}**. No significant differences in the percentage of viable cells between the two cell culture conditions after 48 hours was observed. Specifically, 95.1 ± 2.12% of the cells subjected to simulated microgravity were viable, while 91.1 ± 3.54% of the static control cells were determined to be viable. The average cellular diameter (μm) was determined to be 12.6 ± 0.42 and 12.8 ± 0.28 in TK6 cells subjected to microgravity and control respectively. Similar cellular growth rates between the rotating and static culture conditions facilitated ruling out the possibility of cell growth being the major contributor to the changes in the methylation and gene expression patterns.

Changes in 5mC profile following simulated microgravity {#sec011}
-------------------------------------------------------

We applied MeDIP coupled with high-throughput sequencing to identify the differences in the genome-wide patterns of 5mC upon simulated microgravity on TK6 cells. 2.8x10^8^ and 1.8x10^8^ reads were obtained during MeDIP-seq from TK6 cells subjected to static and simulated microgravity respectively and more than 90% of these reads aligned to the human genome GRCh37/hg19, 2009 Assembly (**[S1 Table](#pone.0147514.s007){ref-type="supplementary-material"} and [S2 Fig](#pone.0147514.s002){ref-type="supplementary-material"}**). Quality assessment generated by FastQC \[[@pone.0147514.ref036]\] showed satisfactory sequence quality for all measures except for GC content. As GC rich regions of the genome are enriched in MeDIP-seq datasets, this result was not unexpected. The depth of sequencing for MeDIP-seq samples ranged from 2.8X to 6.1X **([S1 Table](#pone.0147514.s007){ref-type="supplementary-material"}).** Cross-correlation analysis was performed as per the ENCODE consortium guidelines \[[@pone.0147514.ref042], [@pone.0147514.ref052], [@pone.0147514.ref053]\] and all the samples displayed Normalized Strand Correlation (NSC) and Relative Strand Correlation (RSC) values (**[S1 Table](#pone.0147514.s007){ref-type="supplementary-material"}**) characteristic of "high-quality data sets". The similarity between the replicates was evident as hierarchical dendrogram displayed distinct clustering of biological replicates in two groups (**[S3 Fig](#pone.0147514.s003){ref-type="supplementary-material"}**) and sequence coverage analyses displayed that MeDIP-seq reads generated from the samples covered similar number of bases of the reference genome **([S4 Fig](#pone.0147514.s004){ref-type="supplementary-material"}).**

Differentially methylated region (DMRs) were defined as genomic regions in TK6 cells under simulated microgravity that showed alteration in methylation (either increase or decrease) compared to TK6 cells under static conditions. 3204 DMRs (**[S2 Table](#pone.0147514.s008){ref-type="supplementary-material"} & [S3 Table](#pone.0147514.s009){ref-type="supplementary-material"}**) were detected using the IDR pipeline having an IDR cutoff value of 0.05 or less. Of the total DMRs, 1286 (40.14%) were associated with hypermethylation (gain-of-5mC) (**[S2 Table](#pone.0147514.s008){ref-type="supplementary-material"})** and 1918 (59.86%) with hypomethylation (loss-of-5mC) (**[S3 Table](#pone.0147514.s009){ref-type="supplementary-material"})** upon simulated microgravity respectively. The DMRs were further analyzed to determine the overlap of DMR regions with different genomic features by the methylome analysis pipeline described in details by Wilson et al. \[[@pone.0147514.ref039]\]. Functional genomic distribution analyses indicated that 969 and 1381 genes associated with DMRs have undergone gain-of-5mC and loss-of-5mC respectively (**[Table 1](#pone.0147514.t001){ref-type="table"}**). Also, 105 hypermethylated and 193 hypomethylated DMRs were observed around -1500 to 1500 bps of Transcription Start Sites (TSS) as demonstrated in **Tables [2](#pone.0147514.t002){ref-type="table"} & [3](#pone.0147514.t003){ref-type="table"}**. The distribution of the genomic repeat sequences (LINE, SINE and LTR) located within the DMRs has been represented in **[Table 1](#pone.0147514.t001){ref-type="table"}**. Metadata describing features such as genes, transcripts, Pseudogene, non-coding RNA and other regulatory features present on each DMR has been included in **[S2 Table](#pone.0147514.s008){ref-type="supplementary-material"} & [S3 Table](#pone.0147514.s009){ref-type="supplementary-material"}**. Investigation of annotations from 20 different ontologies from genomic coordinates of DMRs was generated by utilizing Stanford University's Genomic Regions Enrichment of Annotations Tool (GREAT) version 3.0.0 \[[@pone.0147514.ref054]\] and included in **[S4 Table](#pone.0147514.s010){ref-type="supplementary-material"} & [S5 Table](#pone.0147514.s011){ref-type="supplementary-material"}.** Gain-of-5mC DMRs induced by simulated microgravity were found to enrich GO Biological Processes like regulation of metabolic process (GO: 0019222), primary metabolic process (GO: 0044238) and cellular metabolic process (GO: 0044237) **([Fig 2A](#pone.0147514.g002){ref-type="fig"})**. PANTHER Pathway Analysis implicated genes involved in p53 pathway (P00059), PI3 kinase pathway (P00048), T cell activation (P00053) and B cell activation (P00010) to be associated with hypermethylated DMRs **([Fig 2B](#pone.0147514.g002){ref-type="fig"})**. On the other hand, loss-of-5mC DMRs were observed to enrich GO Biological Processes like cellular metabolic process (GO: 0044237) and primary metabolic process (GO: 0044238) **([Fig 2C](#pone.0147514.g002){ref-type="fig"}**). PANTHER Pathway Analysis, revealed that these hypomethylated DMRs were associated with genes involved in EGF receptor signaling (P00018), Apoptosis signaling (P00006) and FGF signaling (P00021) pathways among others **([Fig 2D](#pone.0147514.g002){ref-type="fig"})**.

![Pathways illustrating the network of genomic loci involved with (A & B) Regions undergoing increase in 5mC content and (C & D) decrease in 5mC contents, upon simulated microgravity.](pone.0147514.g002){#pone.0147514.g002}

10.1371/journal.pone.0147514.t001

###### Genome annotation Summary.

The number of genomic features such as CpG islands, CpG shores, ENSEMBL Genes and DNA Repeats (LINE, SINE and LTR) associated with regions undergoing gain-of-5mC/5hmC and loss-of-5mC/5hmC DMRs or DHMRs in TK6 cells cultured under simulated microgravity compared to static condition.

![](pone.0147514.t001){#pone.0147514.t001g}

  Features   DMR   DHMR        
  ---------- ----- ------ ---- ----
  **CpGI**   23    69     1    0
  **CpG**    127   277    5    1
  **Gene**   969   1381   86   7
  **LINE**   421   521    47   1
  **SINE**   944   1973   18   11
  **LTR**    157   227    28   0

10.1371/journal.pone.0147514.t002

###### List of hypermethylated DMRs located within +/- 1500 of Transcription Start Sites of genes.

Columns display the genomic coordinates of DMRs, Gene Symbol of the corresponding gene, the description of the genome and the exact distance in bp.

![](pone.0147514.t002){#pone.0147514.t002g}

  DMR (Chr:Start-End)       Gene Symbol   Description                                                                       Distance
  ------------------------- ------------- --------------------------------------------------------------------------------- ----------
  2:74407290--74407690      MOB1A         MOB kinase activator 1A                                                           -1495
  1:32620788--32621188      KPNA6         karyopherin alpha 6 (importin alpha 7)                                            -1475
  8:48919307--48919707      UBE2V2        ubiquitin-conjugating enzyme E2 variant 2                                         -1453
  20:10644375--10644775     JAG1          jagged 1                                                                          -1421
  19:8526792--8527192       HNRNPM        heterogeneous nuclear ribonucleoprotein M                                         -1389
  10:103579850--103580250   MGEA5         meningioma expressed antigen 5 (hyaluronidase)                                    -1354
  1:176177694--176178094    RFWD2         ring finger and WD repeat domain 2, E3 ubiquitin protein ligase                   -1265
  8:66547493--66547893      ARMC1         armadillo repeat containing 1                                                     -1251
  17:73976545--73976945     ACOX1         acyl-CoA oxidase 1, palmitoyl                                                     -1230
  5:137912163--137912563    HSPA9         heat shock 70kDa protein 9 (mortalin)                                             -1230
  1:9710401--9710801        PIK3CD        phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta           -1189
  17:76820294--76820694     USP36         ubiquitin specific peptidase 36                                                   -1163
  7:144108260--144108660    NOBOX         NOBOX oogenesis homeobox                                                          -1140
  1:179333515--179333915    AXDND1        axonemal dynein light chain domain containing 1                                   -1140
  7:150781644--150782044    AGAP3         ArfGAP with GTPase domain, ankyrin repeat and PH domain 3                         -1110
  3:27765104--27765504      EOMES         eomesodermin                                                                      -1098
  1:27096449--27096849      ARID1A        AT rich interactive domain 1A (SWI-like)                                          -1071
  17:37608338--37608738     MED1          mediator complex subunit 1                                                        -999
  4:94748859--94749259      ATOH1         atonal homolog 1 (Drosophila)                                                     -983
  10:111968848--111969248   MXI1          MAX interactor 1, dimerization protein                                            -941
  20:35488994--35489394     SOGA1         suppressor of glucose, autophagy associated 1                                     -918
  22:51067323--51067723     ARSA          arylsulfatase A                                                                   -916
  10:112630503--112630903   PDCD4         programmed cell death 4 (neoplastic transformation inhibitor)                     -862
  16:75468037--75468437     CFDP1         craniofacial development protein 1                                                -854
  17:4235771--4236171       UBE2G1        ubiquitin-conjugating enzyme E2G 1                                                -753
  17:47492799--47493199     PHB           prohibitin                                                                        -753
  3:99978894--99979294      TBC1D23       TBC1 domain family, member 23                                                     -750
  17:33469869--33470269     NLE1          notchless homolog 1 (Drosophila)                                                  -735
  17:65026584--65026984     AC005544.1    Uncharacterized protein                                                           -725
  2:88895888--88896288      EIF2AK3       eukaryotic translation initiation factor 2-alpha kinase 3                         -713
  1:150265379--150265779    MRPS21        mitochondrial ribosomal protein S21                                               -710
  4:37827346--37827746      PGM2          phosphoglucomutase 2                                                              -709
  20:42573450--42573850     TOX2          TOX high mobility group box family member 2                                       -695
  1:151738242--151738642    OAZ3          ornithine decarboxylase antizyme 3                                                -689
  11:33277352--33277752     HIPK3         homeodomain interacting protein kinase 3                                          -666
  15:60691398--60691798     ANXA2         annexin A2                                                                        -657
  17:3716988--3717388       C17orf85      chromosome 17 open reading frame 85                                               -644
  10:8095826--8096226       GATA3         GATA binding protein 3                                                            -630
  9:123295232--123295632    CDK5RAP2      CDK5 regulatory subunit associated protein 2                                      -599
  7:48019521--48019921      HUS1          HUS1 checkpoint homolog (S. pombe)                                                -571
  12:120109292--120109692   PRKAB1        protein kinase, AMP-activated, beta 1 non-catalytic subunit                       -557
  15:43637360--43637760     ADAL          adenosine deaminase-like                                                          -545
  5:122180427--122180827    SNX24         sorting nexin 24                                                                  -517
  3:113676612--113677012    ZDHHC23       zinc finger, DHHC-type containing 23                                              -489
  19:58400668--58401068     ZNF814        zinc finger protein 814                                                           -463
  14:93184061--93184461     LGMN          legumain                                                                          -457
  20:45280352--45280752     SLC13A3       solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3   -454
  2:8977951--8978351        KIDINS220     kinase D-interacting substrate, 220kDa                                            -391
  20:30639472--30639872     HCK           hemopoietic cell kinase                                                           -319
  5:67521976--67522376      PIK3R1        phosphoinositide-3-kinase, regulatory subunit 1 (alpha)                           -286
  16:25027042--25027442     ARHGAP17      Rho GTPase activating protein 17                                                  -255
  19:11306249--11306649     KANK2         KN motif and ankyrin repeat domains 2                                             -88
  12:110783800--110784200   ATP2A2        ATPase, Ca++ transporting, cardiac muscle, slow twitch 2                          -6
  13:78493694--78494094     EDNRB         endothelin receptor type B                                                        9
  13:111839015--111839415   ARHGEF7       Rho guanine nucleotide exchange factor (GEF) 7                                    14
  3:180633094--180633494    FXR1          fragile X mental retardation, autosomal homolog 1                                 46
  12:122457270--122457670   BCL7A         B-cell CLL/lymphoma 7A                                                            142
  14:95569392--95569792     DICER1        dicer 1, ribonuclease type III                                                    175
  3:64253200--64253600      PRICKLE2      prickle homolog 2 (Drosophila)                                                    255
  19:45445601--45446001     APOC4         apolipoprotein C-IV                                                               270
  13:114549584--114549984   GAS6          growth arrest-specific 6                                                          272
  5:68470171--68470571      CCNB1         cyclin B1                                                                         287
  4:89079332--89079732      ABCG2         ATP-binding cassette, sub-family G (WHITE), member 2                              291
  22:41257564--41257964     DNAJB7        DnaJ (Hsp40) homolog, subfamily B, member 7                                       366
  15:83676793--83677193     C15orf40      chromosome 15 open reading frame 40                                               375
  13:113301551--113301951   C13orf35      chromosome 13 open reading frame 35                                               393
  9:130340673--130341073    FAM129B       family with sequence similarity 129, member B                                     395
  21:34804877--34805277     IFNGR2        interferon gamma receptor 2 (interferon gamma transducer 1)                       451
  12:70728471--70728871     CNOT2         CCR4-NOT transcription complex, subunit 2                                         456
  4:80993052--80993452      ANTXR2        anthrax toxin receptor 2                                                          465
  19:58741108--58741508     ZNF544        zinc finger protein 544                                                           474
  11:85565301--85565701     AP000974.1    CDNA FLJ26432 fis, clone KDN01418; Uncharacterized protein                        485
  19:40831600--40832000     C19orf47      chromosome 19 open reading frame 47                                               530
  5:137070955--137071355    KLHL3         kelch-like family member 3                                                        549
  19:10120383--10120783     COL5A3        collagen, type V, alpha 3                                                         564
  17:78389846--78390246     ENDOV         endonuclease V                                                                    577
  3:101231200--101231600    SENP7         SUMO1/sentrin specific peptidase 7                                                628
  13:28673851--28674251     FLT3          fms-related tyrosine kinase 3                                                     656
  18:32919753--32920153     ZNF24         zinc finger protein 24                                                            665
  2:202644765--202645165    ALS2          amyotrophic lateral sclerosis 2 (juvenile)                                        680
  17:17183036--17183436     COPS3         COP9 constitutive photomorphogenic homolog subunit 3 (Arabidopsis)                778
  19:12661227--12661627     ZNF564        zinc finger protein 564                                                           821
  8:107283104--107283504    OXR1          oxidation resistance 1                                                            831
  2:25390345--25390745      POMC          proopiomelanocortin                                                               895
  3:192959642--192960042    HRASLS        HRAS-like suppressor                                                              928
  19:54662449--54662849     LENG1         leukocyte receptor cluster (LRC) member 1                                         971
  12:100595414--100595814   ACTR6         ARP6 actin-related protein 6 homolog (yeast)                                      985
  13:27828691--27829091     RPL21         ribosomal protein L21                                                             1049
  12:57858360--57858760     GLI1          GLI family zinc finger 1                                                          1085
  17:74476687--74477087     RHBDF2        rhomboid 5 homolog 2 (Drosophila)                                                 1089
  19:38712475--38712875     DPF1          D4, zinc and double PHD fingers family 1                                          1138
  19:53138925--53139325     ZNF83         zinc finger protein 83                                                            1214
  9:6644198--6644598        GLDC          glycine dehydrogenase (decarboxylating)                                           1252
  3:172362558--172362958    AC007919.2    HCG1787166; PRO1163                                                               1275
  17:71230451--71230851     C17orf80      chromosome 17 open reading frame 80                                               1286
  12:123875689--123876089   SETD8         SET domain containing (lysine methyltransferase) 8                                1300
  7:98479823--98480223      TRRAP         transformation/transcription domain-associated protein                            1310
  7:72396789--72397189      POM121        POM121 transmembrane nucleoporin                                                  1329
  4:187646331--187646731    FAT1          FAT tumor suppressor homolog 1 (Drosophila)                                       1345
  2:216256316--216256716    FN1           fibronectin 1                                                                     1354
  17:40654447--40654847     ATP6V0A1      ATPase, H+ transporting, lysosomal V0 subunit a1                                  1387
  12:111857341--111857741   SH2B3         SH2B adaptor protein 3                                                            1397
  12:110925896--110926296   FAM216A       family with sequence similarity 216, member A                                     1400
  2:53996217--53996617      CHAC2         ChaC, cation transport regulator homolog 2 (E. coli)                              1488
  2:947917--948317          SNTG2         syntrophin, gamma 2                                                               1492
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###### List of hypomethylated DMRs located within +/- 1500 of Transcription Start Sites of genes.

Columns display the genomic coordinates of DMRs, Gene Symbol of the corresponding gene, the description of the genome and the exact distance in base pairs.

![](pone.0147514.t003){#pone.0147514.t003g}

  DMR (Chr:Start-End)       Gene Symbol      Description                                                                                                     Distance
  ------------------------- ---------------- --------------------------------------------------------------------------------------------------------------- ----------
  1:45958152--45958568      TESK2            testis-specific kinase 2                                                                                        -1488
  13:21138922--21139338     IFT88            intraflagellar transport 88 homolog (Chlamydomonas)                                                             -1455
  12:6831258--6831674       COPS7A           COP9 constitutive photomorphogenic homolog subunit 7A (Arabidopsis)                                             -1441
  11:107990630--107991046   ACAT1            acetyl-CoA acetyltransferase 1                                                                                  -1405
  19:569701--570117         BSG              basigin (Ok blood group)                                                                                        -1388
  19:54664797--54665213     LENG1            leukocyte receptor cluster (LRC) member 1                                                                       -1385
  14:50232737--50233153     KLHDC2           kelch domain containing 2                                                                                       -1381
  11:47289128--47289544     MADD             MAP-kinase activating death domain                                                                              -1376
  17:33465350--33465766     NLE1             notchless homolog 1 (Drosophila)                                                                                -1372
  2:72372691--72373107      CYP26B1          cytochrome P450, family 26, subfamily B, polypeptide 1                                                          -1355
  20:34543689--34544105     SCAND1           SCAN domain containing 1                                                                                        -1349
  8:76318743--76319159      HNF4G            hepatocyte nuclear factor 4, gamma                                                                              -1320
  17:48946441--48946857     TOB1             transducer of ERBB2, 1                                                                                          -1310
  16:3931818--3932234       CREBBP           CREB binding protein                                                                                            -1299
  2:211306550--211306966    LANCL1           LanC lantibiotic synthetase component C-like 1 (bacterial)                                                      -1289
  1:47780891--47781307      STIL             SCL/TAL1 interrupting locus                                                                                     -1280
  17:16333898--16334314     TRPV2            transient receptor potential cation channel, subfamily V, member 2                                              -1263
  3:12706770--12707186      RAF1             v-raf-1 murine leukemia viral oncogene homolog 1                                                                -1253
  19:49577242--49577658     KCNA7            potassium voltage-gated channel, shaker-related subfamily, member 7                                             -1252
  5:175974933--175975349    CDHR2            cadherin-related family member 2                                                                                -1251
  5:156363707--156364123    TIMD4            T-cell immunoglobulin and mucin domain containing 4                                                             -1228
  12:49111699--49112115     CCNT1            cyclin T1                                                                                                       -1226
  17:79607945--79608361     TSPAN10          tetraspanin 10                                                                                                  -1196
  1:25257327--25257743      RUNX3            runt-related transcription factor 3                                                                             -1167
  12:110460055--110460471   ANKRD13A         ankyrin repeat domain 13A                                                                                       -1161
  22:43011912--43012328     POLDIP3          polymerase (DNA-directed), delta interacting protein 3                                                          -1152
  13:52981570--52981986     THSD1            thrombospondin, type I, domain containing 1                                                                     -1149
  9:103203198--103203614    MSANTD3-TMEFF1   MSANTD3-TMEFF1 readthrough                                                                                      -1147
  9:123584680--123585096    PSMD5            proteasome (prosome, macropain) 26S subunit, non-ATPase, 5                                                      -1144
  19:10827435--10827851     DNM2             dynamin 2                                                                                                       -1112
  1:32404887--32405303      PTP4A2           protein tyrosine phosphatase type IVA, member 2                                                                 -1107
  2:203129141--203129557    NOP58            NOP58 ribonucleoprotein                                                                                         -1090
  12:53474061--53474477     SPRYD3           SPRY domain containing 3                                                                                        -1065
  4:87814423--87814839      C4orf36          chromosome 4 open reading frame 36                                                                              -1062
  17:29157723--29158139     ATAD5            ATPase family, AAA domain containing 5                                                                          -1057
  19:50029617--50030033     RCN3             reticulocalbin 3, EF-hand calcium binding domain                                                                -1050
  9:19150115--19150531      PLIN2            perilipin 2                                                                                                     -1047
  7:138666899--138667315    KIAA1549         KIAA1549                                                                                                        -1043
  11:66446181--66446597     RBM4B            RNA binding motif protein 4B                                                                                    -997
  16:88783445--88783861     PIEZO1           piezo-type mechanosensitive ion channel component 1                                                             -968
  5:176828391--176828807    PFN3             profilin 3                                                                                                      -962
  6:35309180--35309596      PPARD            peroxisome proliferator-activated receptor delta                                                                -947
  3:52805678--52806094      NEK4             NIMA-related kinase 4                                                                                           -921
  14:52291822--52292238     GNG2             guanine nucleotide binding protein (G protein), gamma 2                                                         -883
  1:150292846--150293262    PRPF3            PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae)                                                       -871
  1:28560198--28560614      DNAJC8           DnaJ (Hsp40) homolog, subfamily C, member 8                                                                     -870
  17:1626772--1627188       WDR81            WD repeat domain 81                                                                                             -854
  16:72137332--72137748     DHX38            DEAH (Asp-Glu-Ala-His) box polypeptide 38                                                                       -845
  18:77961381--77961797     PARD6G           par-6 partitioning defective 6 homolog gamma (C. elegans)                                                       -825
  13:42621863--42622279     DGKH             diacylglycerol kinase, eta                                                                                      -818
  13:77461149--77461565     KCTD12           potassium channel tetramerisation domain containing 12                                                          -817
  22:43037207--43037623     ATP5L2           ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G2                                             -808
  15:42076825--42077241     AC073657.1                                                                                                                       -804
  5:170189356--170189772    GABRP            gamma-aminobutyric acid (GABA) A receptor, pi                                                                   -790
  20:34000467--34000883     UQCC             ubiquinol-cytochrome c reductase complex chaperone                                                              -731
  9:99802448--99802864      CTSL2            cathepsin L2                                                                                                    -731
  22:50766008--50766424     DENND6B          DENN/MADD domain containing 6B                                                                                  -727
  22:19279757--19280173     CLTCL1           clathrin, heavy chain-like 1                                                                                    -726
  1:154244054--154244470    HAX1             HCLS1 associated protein X-1                                                                                    -725
  9:125591423--125591839    PDCL             phosducin-like                                                                                                  -721
  15:40401584--40402000     BMF              Bcl2 modifying factor                                                                                           -699
  12:48745657--48746073     ZNF641           zinc finger protein 641                                                                                         -668
  1:107598393--107598809    PRMT6            protein arginine methyltransferase 6                                                                            -666
  5:134073321--134073737    CAMLG            calcium modulating ligand                                                                                       -662
  19:2256862--2257278       JSRP1            junctional sarcoplasmic reticulum protein 1                                                                     -654
  4:17783579--17783995      FAM184B          family with sequence similarity 184, member B                                                                   -652
  6:25965887--25966303      TRIM38           tripartite motif containing 38                                                                                  -649
  2:242186700--242187116    HDLBP            high density lipoprotein binding protein                                                                        -629
  7:43909561--43909977      MRPS24           mitochondrial ribosomal protein S24                                                                             -613
  20:44440411--44440827     UBE2C            ubiquitin-conjugating enzyme E2C                                                                                -596
  8:99075748--99076164      C8orf47          chromosome 8 open reading frame 47                                                                              -583
  8:19680112--19680528      INTS10           integrator complex subunit 10                                                                                   -579
  15:60885693--60886109     RORA             RAR-related orphan receptor A                                                                                   -576
  9:124856243--124856659    TTLL11           tubulin tyrosine ligase-like family, member 11                                                                  -566
  12:123948281--123948697   SNRNP35          small nuclear ribonucleoprotein 35kDa (U11/U12)                                                                 -564
  4:190861171--190861587    FRG1             FSHD region gene 1                                                                                              -564
  19:11450690--11451106     RAB3D            RAB3D, member RAS oncogene family                                                                               -554
  10:126489606--126490022   FAM175B          family with sequence similarity 175, member B                                                                   -540
  7:129691616--129692032    ZC3HC1           zinc finger, C3HC-type containing 1                                                                             -533
  13:103458965--103459381   RP11-484I6.7     BIVM-ERCC5 protein                                                                                              -531
  22:30475426--30475842     HORMAD2          HORMA domain containing 2                                                                                       -529
  3:155463174--155463590    PLCH1            phospholipase C, eta 1                                                                                          -526
  19:39970330--39970746     TIMM50           translocase of inner mitochondrial membrane 50 homolog (S. cerevisiae)                                          -514
  19:56347244--56347660     NLRP4            NLR family, pyrin domain containing 4                                                                           -492
  1:26871647--26872063      RPS6KA1          ribosomal protein S6 kinase, 90kDa, polypeptide 1                                                               -488
  11:62555950--62556366     TMEM179B         transmembrane protein 179B                                                                                      -483
  19:2740422--2740838       SLC39A3          solute carrier family 39 (zinc transporter), member 3                                                           -480
  8:146176515--146176931    ZNF16            zinc finger protein 16                                                                                          -449
  2:175202383--175202799    AC018470.1       Uncharacterized protein FLJ46347                                                                                -440
  3:141120576--141120992    ZBTB38           zinc finger and BTB domain containing 38                                                                        -407
  1:27213196--27213612      GPN2             GPN-loop GTPase 2                                                                                               -388
  19:12946378--12946794     RTBDN            retbindin                                                                                                       -344
  10:28032598--28033014     MKX              mohawk homeobox                                                                                                 -332
  6:44923360--44923776      SUPT3H           suppressor of Ty 3 homolog (S. cerevisiae)                                                                      -321
  21:34926838--34927254     SON              SON DNA binding protein                                                                                         -309
  20:4880379--4880795       SLC23A2          solute carrier family 23 (nucleobase transporters), member 2                                                    -294
  21:45078094--45078510     HSF2BP           heat shock transcription factor 2 binding protein                                                               -277
  13:50070769--50071185     PHF11            PHD finger protein 11                                                                                           -272
  16:22018485--22018901     C16orf52         chromosome 16 open reading frame 52                                                                             -266
  11:17372825--17373241     NCR3LG1          natural killer cell cytotoxicity receptor 3 ligand 1                                                            -240
  20:36149179--36149595     NNAT             neuronatin                                                                                                      -230
  14:96670598--96671014     BDKRB2           bradykinin receptor B2                                                                                          -210
  6:84419386--84419802      SNAP91           synaptosomal-associated protein, 91kDa                                                                          -184
  17:57983959--57984375     RPS6KB1          ribosomal protein S6 kinase, 70kDa, polypeptide 1                                                               -182
  9:130660260--130660676    ST6GALNAC6       ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6   -177
  1:107683060--107683476    NTNG1            netrin G1                                                                                                       -174
  18:2846660--2847076       EMILIN2          elastin microfibril interfacer 2                                                                                -160
  17:73528230--73528646     LLGL2            lethal giant larvae homolog 2 (Drosophila)                                                                      -136
  3:55521255--55521671      WNT5A            wingless-type MMTV integration site family, member 5A                                                           -132
  4:99578749--99579165      TSPAN5           tetraspanin 5                                                                                                   -114
  17:72580766--72581182     C17orf77         chromosome 17 open reading frame 77                                                                             -83
  17:73085977--73086393     SLC16A5          solute carrier family 16, member 5 (monocarboxylic acid transporter 6)                                          -72
  11:62445317--62445733     UBXN1            UBX domain protein 1                                                                                            -70
  2:219906078--219906494    CCDC108          coiled-coil domain containing 108                                                                               -41
  1:47697216--47697632      TAL1             T-cell acute lymphocytic leukemia 1                                                                             -37
  17:73230571--73230987     NUP85            nucleoporin 85kDa                                                                                               -20
  4:111397002--111397418    ENPEP            glutamyl aminopeptidase (aminopeptidase A)                                                                      -19
  19:11658471--11658887     CNN1             calponin 1, basic, smooth muscle                                                                                24
  4:47839834--47840250      CORIN            corin, serine peptidase                                                                                         47
  15:55790255--55790671     DYX1C1           dyslexia susceptibility 1 candidate 1                                                                           83
  21:34924435--34924851     SON              SON DNA binding protein                                                                                         89
  15:57025972--57026388     ZNF280D          zinc finger protein 280D                                                                                        104
  6:137815204--137815620    OLIG3            oligodendrocyte transcription factor 3                                                                          119
  14:23652505--23652921     SLC7A8           solute carrier family 7 (amino acid transporter light chain, L system), member 8                                136
  12:31812613--31813029     METTL20          methyltransferase like 20                                                                                       176
  14:72400014--72400430     RGS6             regulator of G-protein signaling 6                                                                              273
  2:98703769--98704185      VWA3B            von Willebrand factor A domain containing 3B                                                                    278
  3:186281629--186282045    TBCCD1           TBCC domain containing 1                                                                                        297
  6:43112135--43112551      PTK7             PTK7 protein tyrosine kinase 7                                                                                  306
  14:64956734--64957150     ZBTB25           zinc finger and BTB domain containing 25                                                                        309
  2:216239872--216240288    FN1              fibronectin 1                                                                                                   332
  19:14217131--14217547     PRKACA           protein kinase, cAMP-dependent, catalytic, alpha                                                                333
  20:62903727--62904143     PCMTD2           protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2                                    385
  14:32545502--32545918     ARHGAP5          Rho GTPase activating protein 5                                                                                 390
  2:24271847--24272263      C2orf44          chromosome 2 open reading frame 44                                                                              390
  11:63754509--63754925     OTUB1            OTU domain, ubiquitin aldehyde binding 1                                                                        403
  3:188665201--188665617    TPRG1            tumor protein p63 regulated 1                                                                                   406
  5:96294368--96294784      LNPEP            leucyl/cystinyl aminopeptidase                                                                                  421
  1:151694242--151694658    RIIAD1           regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1                                          437
  19:16204630--16205046     TPM4             tropomyosin 4                                                                                                   456
  11:71163246--71163662     DHCR7            7-dehydrocholesterol reductase                                                                                  460
  12:3120506--3120922       TEAD4            TEA domain family member 4                                                                                      504
  1:200012019--200012435    NR5A2            nuclear receptor subfamily 5, group A, member 2                                                                 510
  19:6007516--6007932       RFX2             regulatory factor X, 2 (influences HLA class II expression)                                                     513
  2:216300012--216300428    FN1              fibronectin 1                                                                                                   570
  16:57474089--57474505     CIAPIN1          cytokine induced apoptosis inhibitor 1                                                                          590
  3:42002666--42003082      ULK4             unc-51-like kinase 4 (C. elegans)                                                                               612
  1:228644735--228645151    HIST3H2A         histone cluster 3, H2a                                                                                          617
  19:47735191--47735607     BBC3             BCL2 binding component 3                                                                                        624
  13:36919583--36919999     SPG20            spastic paraplegia 20 (Troyer syndrome)                                                                         629
  22:30477422--30477838     HORMAD2          HORMA domain containing 2                                                                                       630
  2:235404366--235404782    ARL4C            ADP-ribosylation factor-like 4C                                                                                 670
  10:7860937--7861353       TAF3             TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa                                678
  12:58160138--58160554     CYP27B1          cytochrome P450, family 27, subfamily B, polypeptide 1                                                          688
  6:35420636--35421052      FANCE            Fanconi anemia, complementation group E                                                                         706
  19:13988601--13989017     NANOS3           nanos homolog 3 (Drosophila)                                                                                    746
  10:74870845--74871261     NUDT13           nudix (nucleoside diphosphate linked moiety X)-type motif 13                                                    765
  6:27115481--27115897      HIST1H2AH        histone cluster 1, H2ah                                                                                         828
  1:247266524--247266940    ZNF669           zinc finger protein 669                                                                                         848
  19:47216200--47216616     PRKD2            protein kinase D2                                                                                               872
  14:21946061--21946477     TOX4             TOX high mobility group box family member 4                                                                     886
  19:11668857--11669273     ELOF1            elongation factor 1 homolog (S. cerevisiae)                                                                     895
  17:36996603--36997019     C17orf98         chromosome 17 open reading frame 98                                                                             897
  20:31123045--31123461     C20orf112        chromosome 20 open reading frame 112                                                                            947
  12:50786921--50787337     LARP4            La ribonucleoprotein domain family, member 4                                                                    963
  20:62340208--62340624     ZGPAT            zinc finger, CCCH-type with G patch domain                                                                      974
  6:44188171--44188587      SLC29A1          solute carrier family 29 (nucleoside transporters), member 1                                                    986
  3:185001603--185002019    MAP3K13          mitogen-activated protein kinase kinase kinase 13                                                               997
  12:65089089--65089505     AC025262.1       Mesenchymal stem cell protein DSC96                                                                             1032
  9:19050250--19050666      RRAGA            Ras-related GTP binding A                                                                                       1086
  16:1878116--1878532       FAHD1            fumarylacetoacetate hydrolase domain containing 1                                                               1099
  1:35323305--35323721      SMIM12           small integral membrane protein 12                                                                              1133
  20:62461205--62461621     ZBTB46           zinc finger and BTB domain containing 46                                                                        1154
  19:17531871--17532287     MVB12A           multivesicular body subunit 12A                                                                                 1159
  11:638254--638670         DRD4             dopamine receptor D4                                                                                            1169
  15:79576111--79576527     ANKRD34C         ankyrin repeat domain 34C                                                                                       1173
  3:55519903--55520319      WNT5A            wingless-type MMTV integration site family, member 5A                                                           1220
  7:148786349--148786765    ZNF786           zinc finger protein 786                                                                                         1240
  19:39437782--39438198     FBXO17           F-box protein 17                                                                                                1253
  19:47352074--47352490     AP2S1            adaptor-related protein complex 2, sigma 1 subunit                                                              1291
  2:201751795--201752211    PPIL3            peptidylprolyl isomerase (cyclophilin)-like 3                                                                   1299
  12:92529288--92529704     RP11-24B21.1     uncharacterized protein LOC256021 isoform 1                                                                     1301
  1:152007979--152008395    S100A11          S100 calcium binding protein A11                                                                                1324
  13:103424546--103424962   TEX30            testis expressed 30                                                                                             1351
  6:107779175--107779591    PDSS2            prenyl (decaprenyl) diphosphate synthase, subunit 2                                                             1377
  1:31380013--31380429      SDC3             syndecan 3                                                                                                      1387
  22:31004379--31004795     TCN2             transcobalamin II                                                                                               1396
  20:44423810--44424226     DNTTIP1          deoxynucleotidyltransferase, terminal, interacting protein 1                                                    1414
  19:46086441--46086857     OPA3             optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)                                       1428
  3:160115349--160115765    IFT80            intraflagellar transport 80 homolog (Chlamydomonas)                                                             1438
  14:23282743--23283159     SLC7A7           solute carrier family 7 (amino acid transporter light chain, y+L system), member 7                              1440
  18:686337--686753         ENOSF1           enolase superfamily member 1                                                                                    1459
  8:135650448--135650864    ZFAT             zinc finger and AT hook domain containing                                                                       1467

Changes in 5hmC profile upon simulated-microgravity {#sec012}
---------------------------------------------------

We applied hMeDIP analyses coupled with high-throughput sequencing to identify the differences in the genome-wide patterns of 5hmC upon simulated microgravity on TK6 cells. 2.7x10^8^ and 1.4x10^8^ reads were obtained during hMeDIP-seq from TK6 cells under static and simulated microgravity respectively and more than 90% of these read uniquely aligned to the human genome GRCh37/hg19, 2009 Assembly (**[S1 Table](#pone.0147514.s001){ref-type="supplementary-material"} and [S2 Fig](#pone.0147514.s002){ref-type="supplementary-material"}**). The depth of sequencing for the hmeDIP-seq samples ranged from 1.8X to 4.6X depending on the sample (**[S1 Table](#pone.0147514.s007){ref-type="supplementary-material"}**). Cross-correlation analysis was performed as per the ENCODE consortium guidelines \[[@pone.0147514.ref042], [@pone.0147514.ref052], [@pone.0147514.ref053]\] and all the samples displayed Normalized Strand Correlation (NSC) and Relative Strand Correlation (RSC) values greater than the minimum threshold (**[S1 Table](#pone.0147514.s007){ref-type="supplementary-material"}**). The consistency of reads in the biological replicates were observed through the cluster analysis (**[S3 Fig](#pone.0147514.s003){ref-type="supplementary-material"}**) and coverage analysis (**[S5 Fig](#pone.0147514.s005){ref-type="supplementary-material"}**). Of the 167 Differentially Hydroxymethylated Regions (DHMRs) **([S6 Table](#pone.0147514.s012){ref-type="supplementary-material"} & [S7 Table](#pone.0147514.s013){ref-type="supplementary-material"}**) generated at IDR \< 0.05, 154 (92.2%) were associated with hyper-hydroxymethylation (gain-of-5hmC) **([S6 Table](#pone.0147514.s012){ref-type="supplementary-material"})** and 13 (7.8%) with hypo-hydroxymethylation (loss-of-5hmC) (**[S7 Table](#pone.0147514.s013){ref-type="supplementary-material"})** upon simulated microgravity respectively. The overlap of DHMRs with different genomic features indicated that 86 and 7 genes were associated with gain-of-5hmC and loss-of-5hmC DHMRs respectively (**[Table 1](#pone.0147514.t001){ref-type="table"}**). Also, 5 gain-of-5hmC (**[Table 4](#pone.0147514.t004){ref-type="table"}***)* and[2](#pone.0147514.t002){ref-type="table"} loss-of-5hmC (**[Table 5](#pone.0147514.t005){ref-type="table"})** DHMRs were observed around -1500 to 1500 bps of Transcription Start Sites (TSS). The distribution of DNA repeat regions present within the DHMRs was represented in **[Table 1](#pone.0147514.t001){ref-type="table"}**. Metadata describing each DHMR was included in **[S6 Table](#pone.0147514.s012){ref-type="supplementary-material"} & [S7 Table](#pone.0147514.s013){ref-type="supplementary-material"}**. Investigation of GREAT version 3.0.0 ontology annotation \[[@pone.0147514.ref054]\] was included in **[S8 Table](#pone.0147514.s014){ref-type="supplementary-material"}.** Gain-of-5hmC DHMRs induced by simulated microgravity were found to be associated with genes that enriched in GO Biological Processes like positive regulation of B cell activation (GO: 0050871), positive regulation of B cell proliferation (GO: 0030890) and positive regulation of cell-cell adhesion (GO: 0034116) among others **([Fig 3A](#pone.0147514.g003){ref-type="fig"})**. Panther Pathway Analysis of these gan-of-5hmC DHMRs implicated the muscarinic acetylcholine receptor signaling (P00042), insulin/IGF pathway-protein kinase B signaling cascade (P00033) and Fas signaling (P00020) among others (**[Fig 3B](#pone.0147514.g003){ref-type="fig"}**), Due to an extremely small gene set associated with loss-of-5hmC DHMRs, significant p-values of pathway associations were not obtained and have not been reported here.

![Pathways illustrating the network of genomic loci involved with (A & B) Regions undergoing increase in 5hmC content and (C & D) differential gene expression.](pone.0147514.g003){#pone.0147514.g003}

10.1371/journal.pone.0147514.t004

###### List of hyper-hydroxymethylated DHMRs located within +/- 1500 of Transcription Start Sites of genes.

Columns display the genomic coordinates of DHMRs, Gene Symbol of the corresponding gene, the description of the genome and the exact distance in base pairs.

![](pone.0147514.t004){#pone.0147514.t004g}

  DHMR(Chr:Start-End)       Gene Symbol   Description                                        Distance
  ------------------------- ------------- -------------------------------------------------- ----------
  7:73103920--73104390      WBSCR22       Williams Beuren syndrome chromosome region 22      -1091
  19:11319910--11320380     DOCK6         dedicator of cytokinesis 6                         -525
  19:6678748--6679218       C3            complement component 3                             229
  20:29977639--29978109     DEFB119       defensin, beta 119                                 412
  11:117745746--117746216   FXYD6         FXYD domain containing ion transport regulator 6   1359

10.1371/journal.pone.0147514.t005

###### List of hypo-hydroxymethylated DHMRs located within +/- 1500 of Transcription Start Sites of genes.

Columns display the genomic coordinates of DHMRs, Gene Symbol of the corresponding gene, the description of the genome and the exact distance in base pairs

![](pone.0147514.t005){#pone.0147514.t005g}

  DHMR(Chr:Start-End)    Gene Symbol   Description      Distance
  ---------------------- ------------- ---------------- ----------
  3:96336458--96336934   MTRNR2L2      MT-RNR2-like 2   -579
  3:96336159--96336635   MTRNR2L2      MT-RNR2-like 2   -280

Changes in the transcriptome upon simulated-microgravity {#sec013}
--------------------------------------------------------

In TK6 cells, simulated microgravity induced differential expression of 370 transcripts out of 22,376 transcripts analyzed (FDR\<0.1) compared to static control **([S9 Table](#pone.0147514.s015){ref-type="supplementary-material"}).** 271 (73.24%) differentially expressed transcripts were associated with a decrease in expression, while 99 (26.76%) differentially expressed transcripts were associated with an increase in gene expression. 17 (4.59%) genes were associated with a drastic change of differentially expression (greater than 2 fold increase or decrease), while the vast majority were associated with intermediate (0--2 fold) change in differential expression. Furthermore, the pathway analysis **([S10 Table](#pone.0147514.s016){ref-type="supplementary-material"})** of transcriptionally upregulated genes showed enrichment of GO Biological Processes such as response to oxidative stress (GO:0006979) and ion transport (GO:0006811) (**[Fig 3C](#pone.0147514.g003){ref-type="fig"}**), while the downregulated genes could be linked to regulation of DNA-dependent transcription (GO:0006355) and carbohydrate metabolic processes (GO:0005975) (**[Fig 3D](#pone.0147514.g003){ref-type="fig"}).** Some of the top upregulated genes include CHAC1, TRPA1, ATAD3C, INHBE, CTH, HMOX, HBD, SPG20, CACNA1D and PTGER4, while the top downregulated genes were GOLGA6L9, PFKFB4, FBXO17, ITGA6, PIK3R6, SLC2A5, INSIG2, AKAP6, HILPDA and POU2F3 (**[S9 Table](#pone.0147514.s015){ref-type="supplementary-material"}).**

Correlation between simulated microgravity induced DMRS/DHMRs and gene expression {#sec014}
---------------------------------------------------------------------------------

A comparison of the simulated microgravity induced differentially expressed genes (**[S9 Table](#pone.0147514.s015){ref-type="supplementary-material"}**) with DMRs located at gene promoters (**Tables [2](#pone.0147514.t002){ref-type="table"} & [3](#pone.0147514.t003){ref-type="table"}**) revealed that two transcriptionally upregulated genes (TSPAN5 and SPG20) were associated with loss-of-5mC at their promoter and three transcriptionally downregulated genes (PLIN2, MAP3K13 and FBXO1) were associated with loss-of-5mC at their promoter. None of the gene promoters linked to DHMRs (**Tables [4](#pone.0147514.t004){ref-type="table"} & [5](#pone.0147514.t005){ref-type="table"}**) were found to be differentially expressed (**[S9 Table](#pone.0147514.s015){ref-type="supplementary-material"}**). Similarly, the comparison of simulated microgravity induced differentially expressed genes with DMRs/DHMRs located at gene bodies revealed that 25 differentially expressed associated with DMRs at their gene bodies and none of the differentially expressed genes associated with DHMRs at their gene bodies. The relationship between methylation status at gene bodies and their respective transcriptional activity of these 25 differentially expressed genes did not show any significant correlation by Fisher's Exact Test (**[Fig 4A](#pone.0147514.g004){ref-type="fig"}**) and could be divided into five distinct groups, (i) five transcriptionally upregulated genes with loss-of-5mC DMRs at their gene bodies (CTH, CACNA1D, SPG20, PLS1 and SLC39A14), (ii) eleven transcriptionally downregulated genes with loss-of-5mC DMRs at their gene bodies (FBXO17, AKAP6, RIT1, GTF2IRD2P1, MSTO1, PMS2CL, MAP3K13, ST3GAL1, NCKIPSD, MAST1 and MSTO2P), (iii) three transcriptionally downregulated genes associated with gain-of-5mC DMRs at their gene bodies (CACNB2, WDR45B and CABLES1), (iv) three transcriptionally upregulated genes with gain-of-5mC DMRs at their gene bodies (CASZ1, VCL and ATF3) and (v) two transcriptionally upregulated genes with gain-of-5mC as well as loss-of-5mC DMRs at their gene bodies (ARID5B and TSPAN5) (**[Fig 4B](#pone.0147514.g004){ref-type="fig"}**). The comparison of DMRs and DHMRs located at gene bodies (**[S6 Fig](#pone.0147514.s006){ref-type="supplementary-material"}**) yielded six overlapping groups namely (i) 140 genes were associated with gain-of-5mC and loss-of-5mC DMRs at their gene bodies, (ii) eight were genes were associated with loss-of-5mC DMRs and gain-of-5hmC DHMRs, (iii) five gene were associated with gain-of-5mC and loss-of-5mC DMRs as well as gain-of-5hmC DHMRs at their gene bodies, (iv) seven genes were associated with gain-of-5mC DMRs and gain-of-5hmC DHMRs at their gene bodies, (v) one gene was associated with gain-of-5mC DMR and loss-of-5hmC DHMR at its gene body and (vi) two genes were associated with gain-of-5hmC DHMRs and loss-of-5hmC DHMRs at their gene bodies.

![Overlap of simulated microgravity induced differentially expressed genes and genes undergoing differential methylation over gene-bodies (A) Fisher's test showing no significant correlation between direction of methylation changes over gene bodies and their relative expression, (B)Venn diagram showing the overlap of differentially expressed genes with DMRs associated with gene bodies, (C) Statistical Representation of a gene SPG20, which underwent upregulation at the transcript level and a simultaneous decrease in 5mC levels at its promoter upon simulated microgravity.](pone.0147514.g004){#pone.0147514.g004}

Discussion {#sec015}
==========

The objective of this ground-based study was to map the genome-wide effects of simulated microgravity on DNA methylation, hydroxymethylation; and gene expression patterns in TK6 lymphoblastoid cells by a powerful Next Generation Sequencing pipeline. Although on the basis of numerous studies reporting microgravity-induced physiological changes in living organisms ranging from prokaryotes to humans, it has been speculated that microgravity-induced changes may occur in the methylome, very little is known about the effects of microgravity on DNA methylation. In 2009, Ou *et al* reported hypermethylation of a set of genes and transposable elements in rice (*Oryza sativa L*.*)* plants germinating from space-flown seeds \[[@pone.0147514.ref029]\]. Ou *et al* also reported that the spaceflight-induced hypermethylated genes did not generally correlate with alterations in their gene expression status \[[@pone.0147514.ref029]\]. In 2010, Singh *et al* reported that human T-lymphocytes subjected to simulated microgravity underwent global DNA hypomethylation on the basis of Methylation Sensitive-Random Amplified Polymorphic DNA (MS-RAPD)-PCR analysis \[[@pone.0147514.ref030]\]. However, since MS-RAPD-PCR is unable to identify specific methylated sites, the study by Singh *et al* could not report the target genes associated with the simulated-microgravity induced DNA hypomethylation. In 2011, Ou *et al* validated their previous finding that spaceflight induced hypermethylation of DNA (the frequency of spaceflight-induced hypermethylation was demonstrated to be nearly double of spaceflight-induced hypomethylation events) by assessing a larger genomic subset comprising 467 loci \[[@pone.0147514.ref031]\], though it was not evident if any study to correlate changes in DNA methylation with gene expression were further conducted.

The disparity between the conclusions of the studies conducted by Ou *et al* and Singh *et al* could be attributed to several factors, but we think that the following might be important to consider: (i) differences in mechanisms establishing and maintaining DNA methylation patterns in plants and animals (for a comprehensive review refer to \[[@pone.0147514.ref055]\]), (ii) while Ou *et al*'s investigation was based on spaceflight-induced "epigenetic memory" being transmitted from the seeds to the sapling, Singh *et al* had investigated the simulated microgravity-influenced changes in DNA methylation in immortalized T-lymphocyte cell cultures that might not be inheritable and (iii) while Singh *et al* had investigated the effects of only simulated microgravity on DNA methylation, Ou *et al* was investigating the effects of numerous factors like cosmic radiation, microgravity and space magnetic fields encountered during spaceflight. These reports therefore provided a strong basis for us to perform this study with advanced methods such as MeDIP-seq, hMeDIP-seq and RNA-seq to explore the relationship between the methylome and the transcriptome in microgravity exposed cells. To the best of our knowledge, this is the first report profiling the effects of simulated microgravity on the epigenomic landscape of human cells. 3204 DMRs and 2116 DHMRs distributed throughout the genome were identified in TK6 cells subjected to simulated microgravity. The majority of the DMRs (59.86%) were identified to undergo hypomethylation, which was consistent with the findings of Singh *et al* \[[@pone.0147514.ref030]\]. On the other hand the majority of DHMRs (92.2%) were associated with hyper hydroxymethylation.

Additionally, we have been able to perform ontology based annotations to obtain information about the biological processes that might be affected by genes associated with simulated microgravity induced changes occurring in the methylome. In particular, genes involved in primary metabolic processes, immune functions and the p53 pathway seems to be undergoing changes in their methylation/hydroxymethylation status under the influence of simulated microgravity. An early study on lymphoblastoid cells subjected to 48 hours of simulated microgravity by Degan *et al*. reported decrease of cellular ATP content, suggesting a simulated microgravity induced alteration in cellular metabolism \[[@pone.0147514.ref056]\]. It remains to be seen how simulated microgravity induced changes over the methylation levels of p53 effector genes play in TK6 which expresses the wild-type p53 \[[@pone.0147514.ref057]\], a tumor suppressor functioning extensively in the DNA repair pathway. Reduction of global methylation has been proposed to be a hallmark of genomic instability \[[@pone.0147514.ref014], [@pone.0147514.ref058]\] and it remains to be seen if the extensive loss-of-5mC induced by simulated microgravity reported in this study has any functional implications. Another finding in TK6 cell line, which was originally derived from a patient with T- blast crisis \[[@pone.0147514.ref032], [@pone.0147514.ref059], [@pone.0147514.ref060]\] and could potentially harbor progenitor forms of lymphocytes, pertains to changes in methylation/hydroxymethylation patterns over genes involved in lymphocyte development and activation cultured under simulated microgravity conditions. Interestingly whole-exome sequencing has revealed similarities in the genomic content of lymphocytes and lymphoblastoid cells \[[@pone.0147514.ref061]\], and thus in light of our findings TK6 lymphoblastoid cells may emerge as a good model to study B and T- lymphocyte development and activation in *in vitro* genomic studies.

Our study also revealed that simulated microgravity could alter the expression of 370 transcripts, however only 17 of these underwent greater than 2-fold change of up/downregulation. The transcriptionally upregulated genes showed enrichment of pathways involving response to oxidative stress and negative regulation of gene expression, while the downregulated genes could be linked to pathways responsible for glucose metabolism and transcription regulation. While our study illustrated that there was no direct relationship between differentially expressed genes and changes in 5mC/5hmC over its promoters/gene bodies, we have been able to determine the methylation status of individual genes implicated in earlier studies to be affected in transcriptional or translational activities on exposure to simulated microgravity in ground based studies or in spaceflights. For instance, the voltage-dependent calcium channel L-type, alpha 1D (CACNA1D) gene transcript was observed to be differentially expressed in human T-lymphocytes subjected to microgravity conditions during spaceflight compared to ground static controls \[[@pone.0147514.ref049]\]. While, we observed a nominal increase at the transcript level for CACNA1D, we observed a decrease in 5mC levels over its gene body under simulated microgravity.

In another study, the Activating Transcription Factor-3 (ATF3) has been implicated to be differentially expressed upon being subjected to microgravity during spaceflight in cultured HUVEC cells \[[@pone.0147514.ref062]\]. Our RNA-seq data illustrated an increase of 1.3 fold in the transcript level of ATF3 and a decrease in the 5mC levels over its gene body under the influence of simulated microgravity. Interestingly, ATF3, a member of the ATF/CREB family of transcription factors, has been observed to be upregulated when cells are exposed to stress conditions \[[@pone.0147514.ref050]\]. On the other hand, Integrin alpha-6 (ITGA6) which is an integral cell surface protein has been observed to be down-regulated at the transcriptional scale during short-term weightlessness produced by parabolic maneuvers in human cells \[[@pone.0147514.ref051]\]. While RNA-seq revealed a decrease of ITGA6 transcript by more than 2-fold, we were not able to observe changes in the 5mC and 5hmC profile over its gene body or promoter, implying that possibly mechanisms other than DNA methylation might be involved in its regulation.

Some of the novel gene functions that we have linked with DNA methylation status include the F-Box Protein 17 (FBXO17), which constitutes one of the four subunits of the ubiquitin-protein-ligase complex called SKP1-cullin-F-box (SCFs) and mediates substrate specificity \[[@pone.0147514.ref063], [@pone.0147514.ref064]\]. While the transcript level of FBXO17 was observed to be downregulated by 2.47 fold, the 5mC levels over the gene body of FBXO17 (chr19:39437782--39438198) decreased in TK6 cells subjected to simulated microgravity. Recently it has been demonstrated that the recruitment of F-box motif bearing homologous protein in yeast Met30 is regulated by a complex mechanism and has been implicated in stress response \[[@pone.0147514.ref065], [@pone.0147514.ref066]\]. In sync with these observations, reduction of 5mC levels over gene bodies of other F-Box motif containing proteins such as FBXO31 (chr16:87421262--87421678) and FBXO42 (chr1:16674945--16675361) and promoter of FBXO5 (2024 bps upstream of TSS; chr6:153306530--153306946), was also observed though their transcripts were not differentially expressed. Interestingly, genes which function as molecular mechano-sensors like Vinculin (VCL) or mediate stress-signal transduction events like Tetraspan-5 (TSPAN5) were also seen to undergo changes in its gene methylation levels and expression. Similarly, other genes involved in the Metabolic process (GO:0008152) like Cystathionine gamma-lyase (CTH), Phospholipid scramblase-1 (PLS1) Microtubule-associated serine/threonine-protein kinase-1 (MAST1), Zinc finger protein castor homolog-1 (CASZ1), CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase-1 (ST3GAL1), AT-rich interactive domain-containing protein-5B (ARID5B), Mitogen-activated protein kinase-13 (MAP3K13) and Perilipin-2 (PLIN2) were implicated in this study contributing to mechano-stress response. Though our study does not show a global correlation between methylation status and transcriptional activity, the simulated microgravity induced changes over SPG20 (a gene implicated in endosomal trafficking and mitochondrial functions) recapitulates the conventional theory of decrease in promoter methylation corresponding to elevated gene activity. This novel finding suggests that methylation-dependent transcriptional activity is not a genome-wide phenomenon, instead it may be applicable for specific genes.

Thus, in conclusion we believe that 48 hours of treatment with simulated microgravity triggered changes in the transcriptome particularly involving biological processes such as negative regulation of transcription, response to stress and reduction in carbohydrate metabolic processes. This study revealed that simulated microgravity influenced alteration of genome-wide 5mC and 5hmC patterns, however no correlation was found between DMRs/DHMRs situated at gene bodies and promoters and their transcriptional status. While it has been long held that genes with methylated promoters are transcriptionally silent, recent studies have uncovered the association of methylated gene promoters with both transcriptionally active and inactive genes \[[@pone.0147514.ref020], [@pone.0147514.ref021], [@pone.0147514.ref067]--[@pone.0147514.ref070]\]. On the other hand, gene body methylation has been observed to be positively correlated with gene expression in some studies \[[@pone.0147514.ref071], [@pone.0147514.ref072]\] and no such correlation has been found in others \[[@pone.0147514.ref022], [@pone.0147514.ref073]--[@pone.0147514.ref075]\]. Recent deep-sequencing based explorations have challenged the traditional paradigm and illustrated complexities of the nature of relationship between DNA methylation and gene expression \[[@pone.0147514.ref019]--[@pone.0147514.ref025]\]. It is also conceivable that pronounced alterations in epigenetic patterns may take place in cells subjected to prolonged microgravity environments. The ground-based microgravity simulators like the one used in our study have undoubtedly enhanced our understanding of microgravity but it has to be pointed out that the principle of "simulating" microgravity involves changing the direction of Earth's gravity subjected to the samples through continuous rotation and represent "functional near weightlessness". While this is the first study to profile the simulated microgravity induced changes in 5mC/5hmC patterns and gene expression simultaneously providing a perspective of epigenetic alterations we could expect during short-term exposures, our understanding is far from complete. We believe that genes involved in altered biological processes identified in this study will be of considerable interest and provide a valuable resource for future investigations. Finally, in the interest of astronauts who are exposed to microgravity for prolonged periods of time, future studies should focus on performing time course experiments monitoring the influence of "real" and "simulated" microgravity exposure on a variety of models to determine the precise effects of microgravity on the epigenome

Supporting Information {#sec016}
======================

###### TK6 cell count under simulated microgravity (12 rpm) and static (control) conditions in the replicates.

(TIF)

###### 

Click here for additional data file.

###### Sequencing Summary.

The total number of reads (white) and the total number of unique reads aligned to the human genome (blue) obtained by performing hmeDIP-seq and meDIP-seq on TK6 cells cultured under static (control) and simulated microgravity (12 rpm) conditions for 48 hours. [S1 Table](#pone.0147514.s007){ref-type="supplementary-material"} demonstrates the exact numbers and percentage of mapped reads.

(TIF)

###### 

Click here for additional data file.

###### Cluster analysis performed on the reads obtained on meDIP-seq and hmeDIP-seq on TK6 cells cultured under static (control) and simulated microgravity conditions which shows similarities in the biological replicates of each condition.

(TIF)

###### 

Click here for additional data file.

###### Coverage analyses performed in MeDUSA using the MEDIPS bioconductor package on the reads generated from (A) MeDIP-seq on control replicate A, (B) MeDIP-seq on control replicate B, (C) MeDIP-seq on simulated microgravity exposed replicate A and (D) MeDIP-seq on simulated microgravity exposed replicate B, over 28217009 CpG dinucleotides.

Color of these lines represent the fold coverage of the CpGs as shown in the legend.

(TIF)

###### 

Click here for additional data file.

###### Coverage analyses performed in MeDUSA using the MEDIPS bioconductor package on the reads generated from (A) hMeDIP-seq on control replicate A, (B) hMeDIP-seq on control replicate B, (C) hMeDIP-seq on simulated microgravity exposed replicate A and (D) hMeDIP-seq on simulated microgravity exposed replicate B, over 28217009 CpG dinucleotides.

Color of these lines represent the fold coverage of the CpGs as shown in the legend.

(TIF)

###### 

Click here for additional data file.

###### Venn diagram showing overlap of genes whose gene body was found to be associated with DMRs and DHMRs (gain-of-5mC/hmC and loss-of-5mC/hmC)

(TIF)

###### 

Click here for additional data file.

###### Sequencing summary quality statistics.

(XLSX)

###### 

Click here for additional data file.

###### List of simulated microgravity-induced DMRs undergoing hypermethylation.

For every DMR identified, a description of the genomic features found in this region has been provided. The columns represent the following information: (A) Genomic coordinates of the region defined as a DMR and (B) ENCODE IDs of features (such as gene, transcript, pseudogene, non-coding RNA or other regulatory feature) present in the region.

(XLSX)

###### 

Click here for additional data file.

###### List of simulated microgravity-induced DMRs undergoing hypomethylation.

For every DMR identified, a description of the genomic features found in this region has been provided. The columns represent the following information: (A) Genomic coordinates of the region defined as a DMR and (B) ENCODE IDs of features (such as gene, transcript, pseudogene, non-coding RNA or other regulatory feature) present in the region.

(XLSX)

###### 

Click here for additional data file.

###### GREAT Ontology Summary Statistics for hypermethylated DMRs.

The columns represents the respective ontology name, term name / identifier, term description, binomial rank, binomial p-value (uncorrected), binomial Bonferroni corrected p-value, binomial FDR q-value and names of gene hits generated by GREAT version 3.0.0; Species assembly: hg19 and association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included.

(XLSX)

###### 

Click here for additional data file.

###### GREAT Ontology Summary Statistics for hypomethylated DMRs.

The columns represents the respective ontology name, term name / identifier, term description, binomial rank, binomial p-value (uncorrected), binomial Bonferroni corrected p-value, binomial FDR q-value and names of gene hits generated by GREAT version 3.0.0; Species assembly: hg19 and association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included.

(XLSX)

###### 

Click here for additional data file.

###### List of simulated microgravity-induced DHMRs undergoing hyper-hydroxymethylation.

For every DHMR identified, a description of the genomic features found in this region has been provided. The columns represent the following information: (A) Genomic coordinates of the region defined as a DHMR and (B) ENCODE IDs of features (such as gene, transcript, pseudogene, non-coding RNA or other regulatory feature) present in the region.

(XLSX)

###### 

Click here for additional data file.

###### List of simulated microgravity-induced DHMRs undergoing hypo-hydroxymethylation.

The columns represent the following information for each identified DHMR: (A) Genomic coordinates of the region defined as a DHMR and (B) ENCODE IDs of features (such as gene, transcript, pseudogene, non-coding RNA or other regulatory feature) present in the region.

(XLSX)

###### 

Click here for additional data file.

###### GREAT Ontology Summary Statistics for hyperhydroxymethylated DHMRs.

The columns represents the respective ontology name, term name / identifier, term description, binomial rank, binomial p-value (uncorrected), binomial Bonferroni corrected p-value, binomial FDR q-value and names of gene hits generated by GREAT version 3.0.0; Species assembly: hg19 and association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included.

(XLSX)

###### 

Click here for additional data file.

###### List of Differentially Expressed Genes induced by simulated microgravity.

The columns represent geneID, name of gene from UCSC Genome Browser (duplicates exist because multiple geneID can map to same gene), chromosome location, strand: + or--, transcription start position, transcription end position, the log2-fold-change of gene expression, the average log2-counts-per-million of comparison, p-value of comparison, false discovery rate (corrected p-value) of comparison.

(XLSX)

###### 

Click here for additional data file.

###### Pathway Analysis of simulated microgravity induced differentially up and downregulated genes.

(XLSX)

###### 

Click here for additional data file.
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